Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
06/2014
06/18/2014CN103864709A Solvent for preparing oxazolidine
06/18/2014CN101903372B Heteroaryl derivatives as orexin receptor antagonists
06/17/2014US8754214 Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
06/17/2014US8754207 Process for the preparation of rapamycin derivatives
06/17/2014US8754101 N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists
06/17/2014US8754100 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
06/17/2014US8754098 Forms of rifaximin and uses thereof
06/17/2014US8754097 Piperidine and piperazine derivatives
06/17/2014CA2699933C Fungicidal mixtures
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163022 Protein kinase c inhibitors and uses thereof
06/12/2014US20140163002 Cyclic p1 linkers as factor xia inhibitors
06/12/2014US20140163000 Compounds useful as inhibitors of atr kinase
06/12/2014US20140161757 Process for controlling malodors using oxazolidines
06/11/2014EP2739624A1 Fused heterocyclic compound and use thereof for pest control
06/11/2014CN103857659A Fused benzoxazepinones as ion channel modulators
06/11/2014CN103848849A Preparation technology for everolimus
06/11/2014CN103848848A Preparation method of known impurity tacrolimusdiene in tacrolimus
06/11/2014CN103172641B Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof
06/11/2014CN102947289B Arylethynyl derivatives
06/11/2014CN102617729B Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent
06/10/2014US8748455 Solid forms of a pharmaceutically active substance
06/10/2014CA2777664C Macrocyclic integrase inhibitors
06/10/2014CA2771189C Novel dihydro-oxazolobenzodiazepinon derivatives, processes for their preparation and pharmaceutical compositions containing them
06/10/2014CA2635205C Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
06/05/2014WO2014085489A1 Inhibitor of apoptosis protein (iap) antagonists
06/05/2014WO2014082380A1 Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082286A1 Rafamycin analogs and methods for making same
06/05/2014US20140155593 Methods of synthesis and purification of heteroaryl compounds
06/05/2014US20140155422 New Process for the Synthesis of Rifaximin and a New Pseudo-Crystalline Form of Rifaximin Obtained Thereby
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155375 Novel compounds
06/05/2014CA2863243A1 Rafamycin analogs and methods for making same
06/04/2014EP2736906A1 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
06/04/2014CN103842365A Cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists
06/04/2014CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
06/04/2014CN103833771A Benzo five-membered heterocyclic compound serving as protein kinase Mek inhibitor, preparation method and application thereof
06/04/2014CN102408434B Anti-fingerprint pollution compound
06/04/2014CN102140120B Visible photochromic compound and synthesis method and application thereof
06/04/2014CN102083797B Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/03/2014US8742113 Furanone derivative
06/03/2014US8742106 Disubstituted heteroaryl-fused pyridines
06/03/2014US8741947 Biologically active macrolides, compositions, and uses thereof
06/03/2014US8741932 Imidazopyridine derivatives
06/03/2014US8741904 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
06/03/2014US8741897 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
06/03/2014CA2621564C Pyridine derivatives and their use in the treatment of psychotic disorders
05/2014
05/30/2014WO2014081820A1 Small molecule cftr correctors
05/29/2014US20140148450 Novel substituted indole derivatives as gamma secretase modulators
05/29/2014US20140148443 Novel Imidazolines as dual inhibitors of MDM2 and MDMX
05/29/2014US20140148437 Novel compounds as diacylglycerol acyltransferase inhibitors
05/29/2014US20140148433 Bicyclic aza heterocycles, and use thereof
05/29/2014US20140148430 Imidazopyridines syk inhibitors
05/28/2014CN103827122A 利福昔明的形式及其用途 Rifaximin form and its use
05/28/2014CN103827121A 作为V1a拮抗剂的氧基-环己基-4H,6H-5-氧杂-2,3,10b-三氮杂-苯并[e]薁 As a V1a antagonist group - cyclohexyl -4H, 6H-5- oxa -2,3,10b- triaza - benzo [e] azulene
05/28/2014CN103819488A 一种他克莫司已知杂质他克莫司位置异构体的制备方法 A tacrolimus tacrolimus preparation method known impurities Division positional isomers
05/28/2014CN103819487A 利福平新晶型及其制备方法 Rifampicin new polymorphs and its preparation method
05/27/2014US8735588 Nematocidal sulfonamides
05/27/2014US8735419 Forms of rifaximin and uses thereof
05/27/2014US8735387 Oxazolopyrimidines as Edg-1 receptor agonists
05/27/2014CA2789645C Cyclic amine compound and acaricide
05/27/2014CA2524706C Synthesis of substituted heterocyclic compounds
05/22/2014WO2014078733A1 Pictet-spengler ligation for protein chemical modification
05/22/2014WO2014078314A1 Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
05/22/2014WO2014076272A1 Pesticidal compounds
05/22/2014WO2014075874A1 Microbiocidal pyrazole derivatives
05/22/2014WO2014075873A1 Microbiocidal pyrazole derivatives
05/22/2014US20140142299 CDK Inhibitors
05/22/2014US20140142297 Methods for the acylation of maytansinol
05/22/2014US20140142279 Method for peptide synthesis
05/22/2014US20140142100 New macrolides and their use
05/22/2014US20140142096 Fused Substituted Aminopyrrolidine Derivative
05/22/2014US20140142089 Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
05/22/2014US20140142088 Pyridazinone derivatives
05/22/2014US20140141081 Forms of rifaximin and uses thereof
05/21/2014EP2731948A1 Novel substituted indole derivatives as gamma secretase modulators
05/21/2014EP2731940A1 4 - piperidinyl compounds for use as tankyrase inhibitors
05/21/2014CN103805648A 高产安丝菌素发酵工艺 Yield ansamitocin fermentation process
05/21/2014CN103804393A 马波沙星稀土螯合物及其合成方法和应用 Marbofloxacin rare earth chelates and synthetic methods and applications
05/21/2014CN103804392A 两种三联苯并二恶嗪衍生物及其应用 Two kinds of triple-benzo derivatives and their application Dioxazine
05/21/2014CN103804391A 一类治疗神经退行性疾病的化合物及其用途 A class of compounds treatment of neurodegenerative diseases and their use
05/21/2014CN103804382A 一类治疗湿疹的化合物及其用途 A class of compounds and their use to treat eczema
05/21/2014CN103804365A 一类治疗接触性皮炎的化合物及其用途 A class of therapeutic compounds contact dermatitis and their use
05/21/2014CN102850377B 一种盐酸左氧氟沙星的制备方法 Preparation method of levofloxacin hydrochloride
05/20/2014US8729269 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
05/20/2014US8729081 Compositions and methods for treating alcohol use disorders, pain and other diseases
05/20/2014US8729077 Anti-viral compounds, compositions, and methods of use
05/20/2014US8729072 Alkylated piperazine compounds
05/20/2014US8729067 Pharmacological treatment of cognitive impairment
05/20/2014US8729065 Crystalline forms of a pharmaceutical compound
05/20/2014CA2612482C Biologically active compounds obtainable from sorangium cellulosum
05/15/2014WO2014074665A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014074658A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014072984A1 Improved process for isolation and purification of rapamycin from fermentation broth
05/15/2014US20140135494 Quinoxaline Compounds and Derivatives
05/15/2014US20140135339 Macrocyclic derivatives for the treatment of diseases
05/15/2014US20140135305 Methods for treating spinal muscular atrophy
05/15/2014US20140134235 Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
05/15/2014US20140134225 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
05/14/2014EP2730573A1 Methylpiperidine derivative
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 220